StockNews.AI
HAE
StockNews.AI
41 days

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025

1. Haemonetics will release Q1 FY2026 financial results on August 7, 2025. 2. A conference call will follow at 8:00 am ET for analysis. 3. Live webcast is available on Haemonetics' investor relations site. 4. The company focuses on healthcare technologies for hospitals and blood centers. 5. Replay of the call will be accessible for one year post-event.

Earnings
+0.79%Current Return
VS
+0.29%S&P 500
$77.5607/09 04:14 PM EDTEvent Start
$78.1707/10 10:37 PM EDTLatest Updated
5m saved
Insight
Article

FAQ

Why Neutral?

The upcoming earnings release may align with expectations, lacking significant news or forecasts.

How important is it?

Earnings releases generally impact stock prices, but current market conditions project stability.

Why Short Term?

Earnings results can impact short-term stock movements but are expected to be stable.

Related Companies

HLTBDXVAR
, /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, August 7, 2025. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on August 7, 2025. The call can be accessed via teleconference at: Q1 2026 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start. A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/wv7zkgdh  A replay of the conference call and webcast will be available for one year beginning on August 7, 2025 at 11:00 am ET using the conference call webcast link provided in this press release.ABOUT HAEMONETICSHaemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.Investor Contacts: Olga Guyette, Vice President-Investor Relations & Treasury     (781) 356-9763  [email protected]       David Trenk, Manager-Investor Relations(203) 733-4987 [email protected]                                                                                Media Contact:   Josh Gitelson, Sr. Director-Global Communications   (781) 356-9776[email protected] SOURCE Haemonetics Corporation WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News